P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
